BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27043155)

  • 1. Emerging aspects of molecular biomarkers for diagnosis, prognosis and treatment response in rheumatoid arthritis.
    Márquez A; Martín J; Carmona FD
    Expert Rev Mol Diagn; 2016 Jun; 16(6):663-75. PubMed ID: 27043155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the proteomic landscape of rheumatoid arthritis: progress and prospective clinical applications.
    Lourido L; Blanco FJ; Ruiz-Romero C
    Expert Rev Proteomics; 2017 May; 14(5):431-444. PubMed ID: 28425787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomics, proteomics and metabolomics: their emerging roles in the discovery and validation of rheumatoid arthritis biomarkers.
    Castro-Santos P; Laborde CM; Díaz-Peña R
    Clin Exp Rheumatol; 2015; 33(2):279-86. PubMed ID: 25572119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomics, transcriptomics and proteomics to elucidate the pathogenesis of rheumatoid arthritis.
    Song X; Lin Q
    Rheumatol Int; 2017 Aug; 37(8):1257-1265. PubMed ID: 28493174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics: applications to the study of rheumatoid arthritis and osteoarthritis.
    Gobezie R; Millett PJ; Sarracino DS; Evans C; Thornhill TS
    J Am Acad Orthop Surg; 2006 Jun; 14(6):325-32. PubMed ID: 16757672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunities and challenges for the discovery and validation of proteomic biomarkers for common arthritic diseases.
    Ourradi K; Sharif M
    Biomark Med; 2017 Oct; 11(10):877-892. PubMed ID: 28976778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics Approach for the Discovery of Rheumatoid Arthritis Biomarkers Using Mass Spectrometry.
    Mun S; Lee J; Park A; Kim HJ; Lee YJ; Son H; Shin M; Lim MK; Kang HG
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achievements and challenges of proteomics in the study of rheumatoid arthritis.
    Ruiz-Romero C; Blanco FJ
    Curr Top Med Chem; 2013; 13(6):732-42. PubMed ID: 23574522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein profiling and network enrichment analysis in individuals before and after the onset of rheumatoid arthritis.
    Brink M; Lundquist A; Alexeyenko A; Lejon K; Rantapää-Dahlqvist S
    Arthritis Res Ther; 2019 Dec; 21(1):288. PubMed ID: 31842970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for rheumatoid arthritis: making it personal.
    Lindstrom TM; Robinson WH
    Scand J Clin Lab Invest Suppl; 2010; 242():79-84. PubMed ID: 20515283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid Arthritis and miRNAs: A Critical Review through a Functional View.
    Moran-Moguel MC; Petarra-Del Rio S; Mayorquin-Galvan EE; Zavala-Cerna MG
    J Immunol Res; 2018; 2018():2474529. PubMed ID: 29785401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [OMICS and biomarkers of glial tumors].
    Idbaih A
    Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer.
    Judes G; Rifaï K; Daures M; Dubois L; Bignon YJ; Penault-Llorca F; Bernard-Gallon D
    Cancer Lett; 2016 Nov; 382(1):77-85. PubMed ID: 26965997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutrition and Rheumatoid Arthritis in the 'Omics' Era.
    Cassotta M; Forbes-Hernandez TY; Cianciosi D; Elexpuru Zabaleta M; Sumalla Cano S; Dominguez I; Bullon B; Regolo L; Alvarez-Suarez JM; Giampieri F; Battino M
    Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data analysis methods for defining biomarkers from omics data.
    Li C; Gao Z; Su B; Xu G; Lin X
    Anal Bioanal Chem; 2022 Jan; 414(1):235-250. PubMed ID: 34951658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between psoriatic arthritis and psoriasis in multi-omics.
    Gao S; Song H
    Arch Dermatol Res; 2024 May; 316(6):217. PubMed ID: 38787526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biomarkers for prognosis of response to anti-TNF therapy of rheumatoid arthritis: Where do we stand?].
    Stuhlmüller B; Skriner K; Häupl T
    Z Rheumatol; 2015 Nov; 74(9):812-8. PubMed ID: 26347122
    [No Abstract]   [Full Text] [Related]  

  • 18. Current and future trends in biomarker discovery and development of companion diagnostics for arthritis.
    Gibson DS; Bustard MJ; McGeough CM; Murray HA; Crockard MA; McDowell A; Blayney JK; Gardiner PV; Bjourson AJ
    Expert Rev Mol Diagn; 2015 Feb; 15(2):219-34. PubMed ID: 25455156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of An Autoimmune Skin Disease--Psoriasis.
    Jiang S; Hinchliffe TE; Wu T
    Genomics Proteomics Bioinformatics; 2015 Aug; 13(4):224-33. PubMed ID: 26362816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential clinical biomarkers in rheumatoid arthritis with an omic approach.
    Puentes-Osorio Y; Amariles P; Calleja MÁ; Merino V; Díaz-Coronado JC; Taborda D
    Auto Immun Highlights; 2021 May; 12(1):9. PubMed ID: 34059137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.